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ABSTRACT Alterations in the troponin complex can lead to increases or decreases in contractile activity. Most mutations of
troponin that cause hypertrophic cardiomyopathy increase the activity of cardiac muscle ﬁbers. In at least some cases these
mutants stabilize the active state of regulated actin. In contrast, phosphorylation of troponin I at residues 43, 45, and 144 inhibits
muscle contractility. To determine if alterations of troponin I that reduce activity do stabilize the inactive state of actin, we
introduced negative charges at residues 43, 45, and 144 of troponin I to mimic a constitutively phosphorylated state. At saturating
calcium, all mutants decreased ATPase rates relative to wild-type actin-tropomyosin-troponin. Reduced activation of ATPase
activity was seen with a single mutation at S45E and was not further altered by mutating the other two sites. In the presence of low
concentrations of NEM-S1, wild-type troponin was more active than the mutants. At high NEM-S1, the rates of wild-type and
mutants approached the same limiting value. Changes in Ca21 afﬁnity also support the idea that the equilibrium between states of
actin-tropomyosin-troponin was shifted to the inactive state by mutations that mimic troponin I phosphorylation.
INTRODUCTION
Striated muscle contraction is controlled by the actin asso-
ciated regulatory protein complex of three troponin subunits
and tropomyosin (1). Binding of calcium to troponin C ex-
poses a hydrophobic pocket that binds to the switch segment
of troponin I (2,3). This interaction moves the inhibitory loop
of troponin I away from the actin filament; as a result, there is
a cooperative transition of tropomyosin along the actin
filament permitting muscle contraction (4,5). Calcium gives
partial stabilization of the active state whereas binding of
N-ethylmaleimide-S1 (NEM-S1) or other ‘‘activating’’ forms
of S1 produces full activation (6–8). Details of the changes
that occur during activation can be found elsewhere (9–13).
The ATPase rate depends on the fraction of myosin S1 that
is bound to actin and the fraction of actin that is in the active
state. Calcium has little effect on the binding of S1 to actin
during ATP hydrolysis (13) but it has a greater effect on the
binding of activating states of S1 such as rigor S1 and S1-
ADP. Several models have been used to describe actin-
myosin binding (14–17). Regulation of the ATPase rate can
be described by a model in which two or more states of actin
are in equilibrium with each other, creating parallel pathways
for activation of ATP hydrolysis (17,18) (Fig. 1). Actin in the
active state has a higher kcat for actin-activated ATPase acti-
vity (19). This higher rate constant is likely due to a larger
rate constant for product release (20,21).
Alterations in the structure of the regulatory proteins can
significantly alter muscle regulation. Single point mutations
on troponin, such as those associated with hypertrophic
cardiomyopathy, can either activate or inhibit ATPase rates
by altering the distribution of states (22,23). Physiological
modifications of troponin can also alter regulation in normal
and pathological states. One important example of this is
phosphorylation of troponin I by protein kinase C (PKC),
which reduces the calcium sensitivity of force production in
skinned fibers and sliding velocity in motility assays (24).
Protein kinase C is one of the two major signaling kinases
in the heart and acts downstream of adrenergic receptor
stimulation. The phosphorylation sites specific for PKC on
troponin I are Ser-43, Ser-45, and Thr-144 (mouse sequence).
Fig. 2 shows the locations of residues 43, 45, and 144 in the
crystal structure of the core domain of cardiac troponin (25).
The core domain of troponin can be divided into two parts:
the regulatory head and the IT arm comprised of a-helices
from troponin I and troponin T. Thr-144 is located in the
middle of the inhibitory region of cardiac troponin I, which
connects the regulatory head to the IT arm and is not visible
in the crystal structure of the cardiac troponin core domain.
Because of this location, modification of Thr-144 could affect
the myofilament activity, especially in the resting state. Some
studies showed the functional importance of the phosphor-
ylation of Thr-144 (26,27). Residues 43 and 45 are located in
the IT arm region and are close to the C-lobe of cardiac
troponin C, which is known as a ‘‘structural domain’’. Early
studies could not positively identify if residues 43 and 45 are
both phosphorylated by PKC. Subsequent studies, including
those with transgenic animal models, treated residues 43 and
45 as a cluster and indicated that the phosphorylation of
residues 43 and 45 has a large impact on myofilament activity
(24,28,29). Finley and Rosevear showed that the introduction
of negative charges into these two sites destabilized helix G
of the C-lobe of cardiac troponin C in the troponin C-troponin
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I binary complex. They also found that the hydrogen/
deuterium exchange rates were altered in Ca21-binding loops
III and IV of cardiac troponin C (30). Recently Ruse et al.
found that of these two residues only Ser-45 was phosphor-
ylated when they treated isolated cardiac troponin I with PKC
(31). Thus, the obvious question to be answered is whether
the phosphorylation of Ser-45 alone is enough to show as
significant an effect on myofilament activity as that of both
Ser-43 and Ser-45.
About 12 PKC isoforms have been reported so far and they
are classified into three subsets by their activation mecha-
nisms: conventional, novel, and atypical. Each isoform may
have different predilections for phosphorylating the three
sites (32). Some isoforms also phosphorylate residues 22 and
23, which are the protein kinase A phosphorylation sites of
troponin I (27,33,34).
Phosphorylation of troponin I by protein kinase C de-
creases the maximum force and maximum shortening ve-
locity and decreases Ca21 sensitivities of force production,
filament sliding speed, and ATPase rates (24). However, the
role of the individual phosphorylation sites has not been
totally clarified and the mechanism by which phosphoryla-
tion inhibits contraction has not been elucidated.
We examined the effect of introducing charges at specific
sites of troponin I on the mechanism of regulation by using a
glutamate substitution at the three PKC phosphorylation sites
on mouse cardiac troponin I to mimic constitutive phospho-
rylation. These mutations have been shown to accurately
reflect the effects of PKC phosphorylation in muscle fiber
studies (24). We examined the effect of these charges on the
regulation of ATPase activity and the binding of S1-ADP to
actin filaments in solution.
The mutants caused a decrease in ATPase rates at inter-
mediate levels of activity such as at saturating calcium or in
EGTA with low levels of NEM-S1. Binding of S1 to actin in
the presence of ADP was decreased at low levels of S1.
Binding of S1 to actin in the presence of ATP was unaffected.
From these results we conclude that the distribution between
the inactive and active states of actin is shifted to the inactive
state by phosphorylation of troponin I. Neither the binding of
S1 to regulated actin by ATP hydrolysis nor the apparent rate
constant for the fully active state were affected by these
mutations.
MATERIAL AND METHODS
Protein preparation
Actin and myosin were isolated from rabbit back muscle (35). Myosin-S1
was made by digestion of myosin with chymotrypsin (Worthington Bio-
chemical, Freehold, NJ) (36). Tropomyosin was isolated from bovine cardiac
tissue. Human cardiac troponin C in pET3d, mouse cardiac troponin I in
pET3d, and mouse cardiac troponin T in pSBETwere expressed as described
previously (37).
Protein concentrations were determined by absorbance measurements at
280 nm, corrected for scattering at 340 nm, using the following extinction
coefficients (e0.1%) for 280 nm: actin (1.15), myosin-S1 (0.75), tropomyosin
(0.23), troponin (0.37).
Measuring ATPase rates
Rates of (g32P) ATP hydrolysis were determined in the presence and
absence of calcium at 25C, pH 7.0, by measuring the release of 32P (19).
Four time points were taken over a 10–15 min period over which the
production of 32P was linear with time so that the measured velocities were
initial velocities. The buffer generally contained 1 mM ATP, 3 mM MgCl2,
10 mM MOPS, 34 mM NaCl, 1 mM EGTA or 0.5 mM CaCl2, and 1 mM
dithiothreitol. When measuring rates in the absence of NEM-S1, 10 mM
actin and 0.1 mM S1 was used. The concentration of NEM-S1 was then
increased incrementally until the system reached full activation. Virtually all
of the NEM-S1 added bound to actin under these conditions (38). To prevent
competitive inhibition of S1 binding, the actin concentration was increased
FIGURE 2 Crystal structure of human cardiac troponin complex (Protein
Data Bank code, 1J1E). Troponin C is shown in red, troponin I in blue, and
troponin T in green. The phosphorylation sites of protein kinase C on mouse
troponin I are residues S43, S45, and T144. Residues 43 and 45 are shown as
magenta spheres. Residues 136 and 147 (human) are also shown to ap-
proximate the position of the T144 site, which has not yet been structurally
well defined.
FIGURE 1 Schematic showing the parallel pathway model for muscle
regulation. Myosin must be bound to actin in the active state (Aa) for rapid
hydrolysis of ATP. Actomyosin in the inactive state (Ai) does not hydrolyze
ATP at a sufficient rate to drive muscle contraction and the enzymatic
activity of unbound myosin is very low. Ca21 partially shifts the equilibrium
between states to favor the active state but cannot fully activate the filament.
Tight binding forms of myosin or S1 (rigor myosin, myosin-ADP, NEM-S1)
shift the equilibrium to the fully active state. Thus, alterations in troponin I
could potentially alter the equilibrium between states, reduce myosin-ATP
binding, or alter a step within the active pathway.
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by an equal amount to the NEM-S1 added to maintain the same level of free
actin (39). The ratio of actin/tropomyosin/troponin was 7:1.5:1.5. The rates
were adjusted by subtracting the low ATPase activity of free S1 and of
NEM-S1.
Equilibrium S1-ADP binding
Equilibrium binding was measured by the fractional increase in light scat-
tering when titrating an actin solution with myosin S1. Measurements were
made using an Aminco Bowman II luminescence spectrometer (Thermo
Electron, Waltham, MA) with excitation wavelength at 340 and emission at
360 nm. Conditions for the binding experiments were: 25C, pH 7.0, 0.2 mg/
mL bovine serum albumin, 14 units/mL hexokinase, 1 mM glucose, 20 mM
p1,p5-di(adenosine-59)pentaphosphate (AP5A), 2 mM ADP, 20 mMMOPS, 5
mM MgCl2, 88 mM NaCl, 1 mM dithiothreitol, 1 mM EGTA or 0.5 mM
CaCl2. Actin was stored as a 30 mM stock in 4 mM imidazole (pH 7.0), 1 mM
dithiothreitol, 2 mM MgCl2, and 30 mM phalloidin. The phalloidin-actin
concentration was 0.075 mM and the ratio of actin/tropomyosin/troponin was
kept at 1:1:1 to ensure full binding of troponin and tropomyosin at the low
actin concentration used. Details of the binding experiments are described
elsewhere (39).
Calcium binding
Ca21 binding was measured by changes in fluorescence emission intensity
of 2-(49-iodoacetamido-anilino)-naphthalene-6-sulfonic acid (IAANS) at-
tached to Cys-35 of a single Cys mutant cardiac troponin C (C84S) as
described previously (37). The probe was excited at 325 nm. The solu-
tion conditions were 100 mM NaCl, 5 mM MgCl2, 1 mM EGTA, 1 mM
dithiothreitol, and 20 mM MOPS at pH 7.0 and 25C. The free Ca21
concentration was calculated with the WEBMAXC Standard program (40).
Measurements were carried out three to four times for each complex.
Binding during steady-state ATP hydrolysis
Binding was measured by cosedimentation with actin. S1 (0.1 mM) and
variable amounts of actin were mixed in a solution containing 3 mM ATP,
10 mM MOPS, 5 mM MgCl2, 14 mM NaCl, 1 mM dithiothreitol, and
0.5 mM CaCl2 at pH 7. Mixtures were centrifuged for 30 min at 25C at
184,0003 g. The ammonium-EDTA ATPase rates of the supernatants were
measured to determine the fractions of unbound S1 (19). The fractions of
bound S1 were determined from conservation of mass considerations. S1
was clarified by centrifugation immediately before use in binding assays.
Statistics
Data in figures are shown as means with error bars showing standard
deviation. Statistical significance (p , 0.05) was determined using the two-
sample significance t-test to compare means.
RESULTS
We examined ATPase rates in the presence and absence of
calcium for wild-type (WT) troponin and for mutants that
simulate phosphorylation at various sites. Fig. 3 shows that
in the presence of Ca21 all of the mutants had repressed
ATPase rates relative to wild-type (p , 0.05). Ratios of the
ATPase rates (wild-type/mutant) were: 3.3 for S45E, 3.4 for
S43E/S45E, and 4.2 for S43E/S45E/S144E. The introduc-
tion of a single negative charge at position 45 was sufficient
to reduce the Ca21 activated ATPase rate. No significant
differences were observed in the fully inhibited state where
EGTA was added to sequester the free Ca21.
We did a series of studies to determine if the reduction in
ATPase rates by the phosphorylation mimicking mutants
resulted from stabilization of the inactive form of actin. One
way of probing the distribution between inactive and active
states is by an analysis of binding of S1-ADP to actin-
tropomyosin-troponin. Fig. 4 shows a series of such binding
curves measured as a function of increasing free S1-ADP
concentrations. The binding profiles were more sigmoidal
for the mutants. This more pronounced ‘‘S’’ shape with a
greater lag at low concentrations of free S1-ADP is indicative
of stabilization of the inactive state of actin. Although the
effect was observed for the single mutation at position 45, the
effect was greater with increasing numbers of introduced
negative charges. This repression of binding suggests that the
transition to the active state was made more difficult by the
introduction of negative charge on the troponin I. Because
the differences between the wild-type andmutants were small
we confirmed the result with other approaches.
The relative stabilities of the inactive and active states at
any condition can be measured by the degree of activation of
ATPase activity relative to the fully inactive state (EGTA, no
strongly bound S1) and to the fully active state (either Ca21
or EGTA with optimal amounts of strongly bound S1).
NEM-S1 binds to actin but has minimal ATPase activity and
therefore serves as a tool to stabilize the active state of actin.
Fig. 5 shows the results of the NEM-S1 dependent acto-S1
ATPase activities in the presence of Ca21. Rates shown were
corrected for the ATPase activities of both unbound S1 and
NEM-S1. Without NEM-S1, the ATPase rates of the mutants
were 24–30% of the wild-type values. However, at interme-
diate concentrations of NEM-S1 (i.e., 2 mM NEM-S1) the
ATPase rates of the three mutants and the wild-type began to
FIGURE 3 Inhibition of actin-activated ATPase activity by mutants in
both the presence (solid bars) and absence (shaded bars) of Ca21 at 0.05 M
ionic strength. Initial velocities in units of micromolars ATP/s/mM S1 are
shown for wild-type cardiac troponin and the following mutants: S45E,
S43E/S45E, and S43E/S45E/T144E. All rates were corrected for the ATPase
rate of S1 in the absence of actin. Data are presented as mean values 6 SD
(n ¼ 6). Conditions are: 25C, pH 7, 0.1 mM S1, 10 mM actin, 1 mM ATP,
10 mM MOPS, 3 mM MgCl2, 33 mM NaCl, 1 mM dithiothreitol, 0.5 mM
CaCl2, or 1 mM EGTA. Actin/tropomyosin/troponin is 7:1.5:1.5.
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converge (Fig. 5, A–C). At saturation with NEM-S1, the
rates were nearly identical indicating that all troponin types
examined produced the same maximum rate. This conver-
gence of rates is easily seen in Fig. 5 D, which shows the
ratio of ATPase rates as a function of NEM S1 concentration
for each of the mutants. The ratio of rates (mutant/wild-type)
tended to converge to 1 with increasing concentrations of
NEM-S1 for all of the mutants. At 2 mM NEM-S1, the
effects of the single mutation at position 45 were reversed to
a greater extent than the other mutants. However, at 7 mM
NEM-S1, the effect of the triple mutant was most completely
reversed. Thus the three mutations showed minor differences
but overall behaved similarly.
As shown earlier in Fig. 3, no significant difference was
seen between any mutant and wild-type in the absence of
both Ca21 and NEM-S1 (p. 0.05). One reason for a lack of
inhibition in EGTA is that the ATPase activity was already
near its minimum value in the case of wild-type troponin. To
ascertain whether the depression of ATPase rates also
occurred in the absence of Ca21, we examined the effect of
partial activation with NEM-S1. Fig. 6 shows that whereas
the ATPase rates were similar in the absence of NEM-S1, the
rates were lower for the phosphorylation mimicking mutants
in the presence of NEM-S1 (p, 0.05 for NEM-S1¼ 4 mM).
Thus, the introduction of negative charges at positions 43,
45, and 144 of cardiac troponin stabilized the inactive state
of regulated actin in both the presence and absence of Ca21.
Ca21 activates thin filaments because it binds more tightly
to the active state of thin filaments and produces the confor-
mational changes that were discussed earlier. Thus, one
would expect that mutations of troponin I that stabilize the
inactive state should weaken Ca21 binding. Wemeasured the
Ca21 affinity for the mutants S45E and S43E/S45E/T144E
along with the wild-type ternary troponin complex using
the fluorescence of an IAANS probe on troponin C (Fig. 7).
The normalized data show reductions in calcium affinity for the
troponin complexes with phosphorylation mimicking muta-
tions as compared to wild-type (p, 0.0001). The association
constants6SD for Ca21 of the troponin complexeswere: wild-
type Ka¼ 5.456 0.103 106 (M1), S45E Ka¼ 2.126 0.04
3 106 (M1), S43E/S45E/T144E Ka ¼ 1.76 6 0.01 3 106
(M1). The S45E mutation was sufficient for producing most
of the observed effect on Ca21 affinity. Note that the affinity
was not reduced to such an extent that full Ca21 binding under
the conditions of Figs. 3 or 5 would be prevented.
Reduced binding of S1 to regulated actin during steady-
state ATP hydrolysis could also cause a decreased activation
of ATPase activity by actin. Fig. 8 shows that the amount of
S1 bound to actin during ATP hydrolysis was similar for
wild-type and all mutants at both 20 and 30 mM actin. Differ-
ences in binding could not have explained the observed dif-
ferences in activation of ATPase rates.
DISCUSSION
Mutants of troponin I that constitutively mimic PKC phos-
phorylation produced a modest reduction in the ability of
actin-tropomyosin-troponin to activate the ATPase activity
of myosin S1 at intermediate levels of activation with
NEM-S1 (Figs. 5 and 6). In the case of activation by Ca21
FIGURE 4 Representative curves showing binding of S1-ADP to actin-
tropomyosin-troponin in the absence of Ca21 at 120 mM ionic strength.
Binding curves for each mutant were repeated three to four times. (A) The
binding of WT (circles) and mutant 45 (squares) with increasing S1-ADP
concentrations; (B) WT (circles) and mutant 43/45 (squares); (C) WT
(circles) and mutant 43/45/144 (squares). Insets show saturation: x axis, [S1-
ADP]Free (0–1 mM); y axis, ActinBound/ActinTotal (0–1.1). Conditions are:
25C, pH 7, 0.075 mM phalloidin-actin, 0.2 mg/mL BSA, 14 units/mL
hexokinase, 1 mM glucose, 20 mM AP5A, 2 mM ADP, 20 mM MOPS, 5
mM MgCl2, 88 mM NaCl, 1 mM dithiothreitol, 1 mM EGTA. Actin/
tropomyosin/troponin was 1:1:1. Light scattering was used to measure the
binding with excitation at 340 nm and emission at 360 nm.
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alone, ATPase rates were reduced to approximately one-third
of wild-type values so that there was little activation by Ca21
with the mutants. In the case of partial activation by NEM-S1
in the absence of Ca21, ATPase rates were reduced to;50%
of wild-type values. These results are consistent with
stabilization of the inactive state of actin by the negatively
charged troponin I mutants.
The same conclusion may be reached from earlier results
with the same mutants and with troponin I that was
phosphorylated by PKC (24). In that study the introduction
of negative charges at sites 43, 45, and 144 resulted in a
reduced Ca21 sensitivity, reduced maximum force in Ca21
and a reduced sliding speed in Ca21 with the actin filament
gliding assay. However the magnitude of the results seen here
FIGURE 5 Actin-activated ATPase activity of
S1 with increasing concentrations of activating
NEM-S1 in the presence of Ca21. The transition of
the regulated acto-S1 complex to maximal ATPase
activity with NEM-S1 binding was blunted with
the mutants. (A) The rates of mutant 45 (solid bars)
and WT (shaded bars) with increasing NEM-S1
concentration; (B) mutant 43/45 (solid bars) and
WT (shaded bars); (C) mutant 43/45/144 (solid
bars) and WT (shaded bars). All rates were cor-
rected for the ATPase rate of S1 and NEM-S1. (D)
The ratio between the mean rates of the various
mutants to the wild-type with (mutant 45)/(WT),
(mutant 43/45)/(WT), and (mutant 43/45/144)/
(WT) at different NEM-S1 concentrations (0, 2,
and 7 mM). Data for panels A, B, and C are pres-
ented as mean values 6 SD with the number of
trials in parentheses. Conditions are: 25C, pH 7,
0.1 mM S1, 10 mM actin, 1 mM ATP, 10 mM
MOPS, 3 mM MgCl2, 33 mM NaCl, 1 mM
dithiothreitol, 0.5 mM CaCl2. Actin concentration
was increased by an amount equal to the NEM-S1
added to maintain the same free actin concentra-
tion. Actin/tropomyosin/troponin was 7:1.5:1.5.
FIGURE 6 Actin-activated ATPase activity in
the absence of Ca21 with increasing concentrations
of NEM-S1. (A) The rates of mutant 45 (solid bars)
and WT (shaded bars); (B) mutant 43/45 (solid
bars) and WT (shaded bars); and (C) mutant 43/
45/144 (solid bars) andWT (shaded bars). (D) The
ratio of mean ATPase rates with (mutant 45)/(WT),
(mutant 43/45)/(WT), and (mutant 43/45/144)/
(WT) at different NEM-S1 concentrations (0, 0.5,
1, 4 mM). All rates were corrected for the ATPase
rate of S1 and NEM-S1. Data for panels A, B, andC
are presented as mean values 6 SD with the
number of trials in parentheses. Conditions are:
25C, pH 7, 0.1 or 0.2 mM S1, 10 mM actin, 1 mM
ATP, 10 mM MOPS, 3 mM MgCl2, 33 mM NaCl,
1 mM dithiothreitol, 1 mMEGTA. Actin concentra-
tion was increased by an equal amount as the NEM-
S1 added to maintain the same number of binding
sites. Actin/tropomyosin/troponin was 7:1.5:1.5.
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for ATPase rates is somewhat different than observed earlier
in other assays. ATPase rates in solution are never reduced
to zero although there may be essentially no movement of
muscle filaments. A greater activity in the absence of Ca21 in
ATPase assays than in gliding assays may be due to partial
activation of the actin filaments in the ATPase assay.
However, the concentration of unmodified S1 present in
ATPase assays is too low to stabilize the active state of actin
even if all of the S1 bound in a rigor-like state in the presence
of ATP. Alternatively, the presence of a small load in the
actin gliding assays might result in no movement despite low
levels of ATPase activation.
Mutants that mimic phosphorylation of troponin I allow
the effects of changes in individual amino acid residues to be
examined. We observed that introduction of a negative charge
into position S45 of cardiac troponin I near the troponin C
binding site was sufficient for producing the changes reported
here. Introduction of additional negative charges at positions
43 and 144 produced little or no additional inhibition of
ATPase activity.
Our ATPase rates were measured at 50 mM ionic strength
to obtain reasonable actin activation. The electrostatic shielding
in solution is half as great at 50 mM ionic strength as it is at
physiological conditions (;180mM) and onemay expect the
effects of a single negative charge to less important at
physiological conditions. We do not think that this is the case
for several reasons. At 50 mM ionic strength a single charge
at S45 produced a maximum effect on ATPase activity. At
120 mM ionic strength a single charge at S45 produced a near
maximum effect on S1-ADP binding. That is, there may have
been a slight attenuation of the charge effect at the higher
ionic strength. Should this small attenuation be real, it may be
compensated for by the higher charge of a naturally occurring
phosphate group compared to an experimental introduced
carboxyl group.
The work shown here was designed to determine the
reason for the reduced activity of actin filaments containing
phosphorylated troponin. A simple scheme of the regulation
of ATP hydrolysis is shown in Fig. 1. Myosin S1 hydrolyzes
ATP slowly if it is detached from actin. Maximum ATPase
activity is obtained when all of the S1 is bound to actin that is
in the active state (Aa). Little or no activation of ATPase
activity occurs when S1 is bound to actin in the inactive state
(Ai). Thus, changes in the regulatory complex may alter the
ATPase activity by: 1), inhibiting the binding of S1 to actin
during ATP hydrolysis, 2), reducing the rate of a transition
along the pathway where S1 is bound to activated actin, or
3), shifting the equilibrium of the actin states toward the
inactive state. Several of our observations indicate that the
reduced ability of the troponin I mutants to stimulate ATPase
activity was the result of stabilization of the inactive state of
regulated actin.
First, we eliminated two possible effects of the mutations.
We found no differences between the troponin I mutants and
wild-type in the amount of S1 bound to actin during steady-
state ATP hydrolysis as shown in Fig. 8. Note that because
binding of S1-ATP is largely independent of the state of
actin-tropomyosin-troponin (19,41) this observation tells us
nothing about the distribution among actin states. We also
ruled out large changes in other steps of the pathway of the
fully activated step. That is, when NEM-S1 was used to
stabilize the fully activated state of regulated actin the rates
of ATPase activity were similar for all cases examined.
These observations indicate that the inhibition of actin
activated ATPase activity could be attributed to stabilization
of the inactive state, Ai.
Several observations pointed directly to stabilization of
the inactive state of actin. The transition from the inactive
state to the active state of regulated actin required higher
concentrations of free S1-ADP for the mutants. This indicates
that the equilibrium between the inactive and active states (Ai
FIGURE 7 Binding of calcium to various troponin complexes including
wild-type (circles), mutant 45 (squares), and mutant 43/45/144 (triangles).
Binding was decreased for both mutants (n¼ 3–4). The conditions were 100
mM NaCl, 5 mM MgCl2, 1 mM EGTA, 1 mM dithiothreitol, and 20 mM
MOPS, pH 7.0, and the titration was carried out at 25C.
FIGURE 8 Effects of troponin I mutations on binding of S1 to actin in the
presence of ATP. Mean values of the fraction of S1-ATP bound with
different actin concentrations at 0.04 M ionic strength are shown6 SD (n¼
3). Binding conditions are: 25C, pH 7, 0.1 mM S1, 3 mM ATP, 10 mM
MOPS, 5 mM MgCl2, 14 mM NaCl, 1 mM dithiothreitol, 0.5 mM CaCl2.
There was no significant difference in binding between the wild-type and
mutants at the actin concentrations measured.
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to Aa in Fig. 1) is shifted more toward the inactive states in the
case of the mutants.
We confirmed stabilization of the inactive state by using
ATPase assays in the presence of NEM-S1 to determine the
fraction of maximum activation under each condition. In the
absence of bound Ca21 and activating myosin essentially all
of actin is in the inactive state, Ai. At saturating concentra-
tions of NEM-S1, the actin filaments have their greatest
activity and essentially all of the actin is in the active state
Aa. We observed that saturating Ca
21 produced a lower frac-
tion of actin in the active state in the case of the phospho-
rylation mimicking mutants of troponin I than for wild-type
troponin. Low levels of NEM-S1 in the absence of Ca21 also
failed to be as effective in stabilizing the active state of the
mutants. These results confirm that the inactive state was
stabilized relative to the active state.
Finally, the lower affinity of Ca21 for the ternary complex
is consistent with stabilization of the inactive state. That is,
Ca21 binds more tightly to troponin that is the active state
than to troponin in the inactive state. Stabilization of the
inactive state would be reflected as a lower Ca21 affinity.
These results suggest that alterations of troponin-tropo-
myosin may change the ATPase activity and Ca21 sensitivity
of the actin filament by a relatively simple mechanism.
Activation of ATPase rates by some mutations in troponin T
have been shown to result from stabilization of the active
state of actin (22). We show here that mutations of troponin I
that inhibit ATPase activity can act by stabilization of the
inactive state. That is, it is possible to have diverse effects on
the activity by altering a single transition between the
inactive and active states of regulated actin. That muta-
tions of components of a cooperative system should have a
primary effect on the transition between the structural states
is easy to visualize. The prevailing view of regulation is that
troponin serves to stabilize tropomyosin into different states
on actin that determine the ability of actin to accelerate ATP
hydrolysis (14,15,42). Small changes in troponin or tropo-
myosin might readily alter the equilibrium between states of
actin to stabilize to a greater extent either the less active or
more active configuration.
PKC phosphorylation in the heart is a normal adaptive
response that is altered in several disease states. PKC activity
is increased in ischemic hearts when the calcium levels are
raised. This activity has been shown to have a protective
effect during myocardial infarction, although the mechanism
remains unclear (43). Excessive phosphorylation has also
been seen in end stages of hypertrophic cardiomyopathy
although it remains unclear whether this is a primary
mechanism contributing to the hypertrophy or an adaptive
response (44). An adaptive response to the mutations that
cause hypertrophy is easily reconciled by the observations
that troponin I phosphorylation stabilizes the inactive state
of actin, whereas some examined troponin T mutants that
produce cardiomyopathy stabilize the active state. Further-
more, as troponin I phosphorylation and mutations of some
troponin T residues affect the same transition in regulation
this would appear to be an ideal adaptive response. However,
activation of PKC in cardiac muscle is complex because of
the different signaling pathways available, the presence of
several isoforms of PKC and the compartmentation of PKC
within cardiac cells (44–47).
This work shows that phosphorylation of troponin I at
residues 43, 45, and 144 stabilize the inactive state of regu-
lation but do not prevent full activation by strongly attached
cross-bridges. Other changes in troponin, such as with some
hypertrophic-cardiomyopathy-causing mutants, stabilize the
active state of regulated actin (22,48). Thus, changes in the
distribution among actin states may be expected to occur with
other changes in the troponin-tropomyosin complex.
This work was supported by National Institutes of Health grants
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